NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
Back to search
Official data from USPTO
FUSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
07/11/2023
Trademark type
Word
Nice classes
5
Filing date
01/04/2021
Registration date
07/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
07/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/27/2023
First use in commerce
03/27/2023
Drawing code
4
Owner type
03
Owner location
Hamilton, Ontario, CA
Examiner
JACKSON, SHA-KARA ELOUISE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Fusion Pharmaceuticals Inc.
Representatives
Jonathan M. Gelchinsky PIERCE ATWOOD LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/08/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/06/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/06/2023
IUAF
USE AMENDMENT FILED
05/15/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/04/2023
EX1G
SOU EXTENSION 1 GRANTED
05/02/2023
EXT1
SOU EXTENSION 1 FILED
05/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/02/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/10/2022
GNRT
NON-FINAL ACTION E-MAILED
01/10/2022
CNRT
NON-FINAL ACTION WRITTEN
01/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/22/2021
GNRT
NON-FINAL ACTION E-MAILED
07/22/2021
CNRT
NON-FINAL ACTION WRITTEN
07/22/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2021
NWAP
NEW APPLICATION ENTERED
01/07/2021
Continuous trademark protection
Get notified about every new filing that threatens FUSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.